Soligenix
SNGX
#11026
Rank
NZ$9.54 M
Marketcap
NZ$0.41
Share price
-6.71%
Change (1 day)
-82.62%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -NZ$20.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$21.62 Million a decrease over its 2024 earnings that were of -NZ$17.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$20.01 Million-7.49%
2025 -NZ$21.62 Million26.72%
2024 -NZ$17.07 Million22.96%
2023 -NZ$13.88 Million-45.74%
2022 -NZ$25.57 Million11.88%
2021 -NZ$22.86 Million-32.37%
2020 -NZ$33.8 Million83.18%
2019 -NZ$18.45 Million11.57%
2018 -NZ$16.54 Million19.29%
2017 -NZ$13.86 Million33%
2016 -NZ$10.43 Million-19.7%
2015 -NZ$12.98 Million5.16%
2014 -NZ$12.35 Million
2010 -NZ$13.93 Million26.12%
2009 -NZ$11.05 Million75.1%
2008 -NZ$6.31 Million-45.38%
2007 -NZ$11.55 Million-22.84%
2006 -NZ$14.97 Million66.15%
2005 -NZ$9.01 Million-16.65%
2004 -NZ$10.81 Million13.28%
2003 -NZ$9.54 Million-11.88%
2002 -NZ$10.83 Million-59.44%
2001 -NZ$26.7 Million378.18%
2000 -NZ$5.59 Million-38.53%
1999 -NZ$9.09 Million-18.43%
1998 -NZ$11.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.16 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.71 B-59,636.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.21 B-66,642.75%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$33.14 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$76.22 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.23 B-10,558.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$5.03 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion 1,562.71%๐Ÿ‡บ๐Ÿ‡ธ USA